These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10884733)

  • 1. Infants exposed to MRI in utero have a normal paediatric assessment at 9 months of age.
    Clements H; Duncan KR; Fielding K; Gowland PA; Johnson IR; Baker PN
    Br J Radiol; 2000 Feb; 73(866):190-4. PubMed ID: 10884733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to detect intrauterine growth restriction following in utero exposure to MRI.
    Myers C; Duncan KR; Gowland PA; Johnson IR; Baker PN
    Br J Radiol; 1998 May; 71(845):549-51. PubMed ID: 9691901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
    Lewis AJ; Galbally M; Opie G; Buist A
    Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal magnetic resonance imaging: exposure times and functional outcomes at preschool age.
    Bouyssi-Kobar M; du Plessis AJ; Robertson RL; Limperopoulos C
    Pediatr Radiol; 2015 Nov; 45(12):1823-30. PubMed ID: 26155983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls.
    Cardonick EH; Gringlas MB; Hunter K; Greenspan J
    Am J Obstet Gynecol; 2015 May; 212(5):658.e1-8. PubMed ID: 25434835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of harmful effects of magnetic resonance exposure at 1.5 T in utero during the third trimester of pregnancy: a follow-up study.
    Kok RD; de Vries MM; Heerschap A; van den Berg PP
    Magn Reson Imaging; 2004 Jul; 22(6):851-4. PubMed ID: 15234454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I; McCulloch KM; Raju TN
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance.
    Fetters L; Tronick EZ
    Pediatrics; 1996 Nov; 98(5):938-43. PubMed ID: 8909489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of low birth weight: a community based prospective cohort study.
    Hirve SS; Ganatra BR
    Indian Pediatr; 1994 Oct; 31(10):1221-5. PubMed ID: 7875782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal cell phone use and developmental milestone delays among infants.
    Divan HA; Kheifets L; Olsen J
    Scand J Work Environ Health; 2011 Jul; 37(4):341-8. PubMed ID: 21403981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.
    Veiby G; Engelsen BA; Gilhus NE
    JAMA Neurol; 2013 Nov; 70(11):1367-74. PubMed ID: 24061295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prenatal maternal stress impair cognitive development and alter temperament characteristics in toddlers with healthy birth outcomes?
    Zhu P; Sun MS; Hao JH; Chen YJ; Jiang XM; Tao RX; Huang K; Tao FB
    Dev Med Child Neurol; 2014 Mar; 56(3):283-9. PubMed ID: 24512346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
    Idris I; Srinivasan R; Simm A; Page RC
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopment of adopted children exposed in utero to cocaine.
    Nulman I; Rovet J; Altmann D; Bradley C; Einarson T; Koren G
    CMAJ; 1994 Dec; 151(11):1591-7. PubMed ID: 7954158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year follow-up of children imaged in utero with echo-planar magnetic resonance.
    Baker PN; Johnson IR; Harvey PR; Gowland PA; Mansfield P
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):32-3. PubMed ID: 8296840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood.
    Chiriboga CA; Vibbert M; Malouf R; Suarez MS; Abrams EJ; Heagarty MC; Brust JC; Hauser WA
    Pediatrics; 1995 Dec; 96(6):1070-7. PubMed ID: 7491223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term.
    Eriksson L; Haglund B; Ewald U; Odlind V; Kieler H
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1415-21. PubMed ID: 23006062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-care utilization among mothers and infants following cocaine exposure.
    Shankaran S; Bauer CR; Bada HS; Lester B; Wright LL; Das A
    J Perinatol; 2003; 23(5):361-7. PubMed ID: 12847529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.